...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: What's the deal with Zenith?
3
Jun 21, 2023 04:54PM
3
Jun 22, 2023 07:41AM
6
Jun 22, 2023 02:26PM

ZCC could buy a boat load of RVX shares at todays prices for next to nothing and have control of the company RVX which may be good.

Existing RVX shareholders would get diluted accordingly, no? Unless there were a willing seller at today's prices which I can't imagine anyone lining up to sell at 10 cents.

3
Jun 23, 2023 01:54AM
1
Jun 23, 2023 02:15AM
3
Jun 23, 2023 10:24AM
5
Jun 24, 2023 08:49AM
Share
New Message
Please login to post a reply